New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
How curiosity sparked pioneering cancer research

How curiosity sparked pioneering cancer research

bySingapore University of Technology and DesignCredit: Pixabay/CC0 Public Domain"I did this research by chance. I was enrolled at the Koch Institute for Integrative Cancer Research at MIT f
World medicine December 07,2023
How curiosity sparked pioneering cancer research

How curiosity sparked pioneering cancer research

bySingapore University of Technology and DesignCredit: Pixabay/CC0 Public Domain"I did this research by chance. I was enrolled at the Koch Institute for Integrative Cancer Research at MIT f
World medicine December 07,2023
Killing 'sleeper cells' may enhance breast cancer therapy

Killing 'sleeper cells' may enhance breast cancer therapy

byWalter and Eliza Hall Institute of Medical ResearchCancer cell during cell division. Credit: National Institutes of HealthThe anti-cancer medicine venetoclax could improve the current therapy
World medicine December 07,2023
Killing 'sleeper cells' may enhance breast cancer therapy

Killing 'sleeper cells' may enhance breast cancer therapy

byWalter and Eliza Hall Institute of Medical ResearchCancer cell during cell division. Credit: National Institutes of HealthThe anti-cancer medicine venetoclax could improve the current therapy
World medicine December 07,2023
Proteome of rare liver cancer sheds new light on basic biology

Proteome of rare liver cancer sheds new light on basic biology

byRockefeller UniversityPathways involved in metabolism of ammonia. Proteins are in ovals and metabolites are in rectangles. Those in green are proteins or metabolites increased in FLC cells, an
World medicine December 07,2023
Proteome of rare liver cancer sheds new light on basic biology

Proteome of rare liver cancer sheds new light on basic biology

byRockefeller UniversityPathways involved in metabolism of ammonia. Proteins are in ovals and metabolites are in rectangles. Those in green are proteins or metabolites increased in FLC cells, an
World medicine December 07,2023
Human uterus colonized by clones with cancer-driving mutations that arise early in life

Human uterus colonized by clones with cancer-driving mutations that arise early in life

byWellcome Trust Sanger InstituteCancer cell during cell division. Credit: National Institutes of HealthMany cells in the inner lining of the uterus carry 'cancer-driving' mutations that
World medicine December 07,2023
Human uterus colonized by clones with cancer-driving mutations that arise early in life

Human uterus colonized by clones with cancer-driving mutations that arise early in life

byWellcome Trust Sanger InstituteCancer cell during cell division. Credit: National Institutes of HealthMany cells in the inner lining of the uterus carry 'cancer-driving' mutations that
World medicine December 07,2023
Rare brain tumor responds to targeted tumor treatment with 'unprecedented' success

Rare brain tumor responds to targeted tumor treatment with 'unprecedented' success

byMass General BrighamCredit: Pixabay/CC0 Public DomainPapillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients. While surgery and radiati
World medicine December 07,2023
Rare brain tumor responds to targeted tumor treatment with 'unprecedented' success

Rare brain tumor responds to targeted tumor treatment with 'unprecedented' success

byMass General BrighamCredit: Pixabay/CC0 Public DomainPapillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients. While surgery and radiati
World medicine December 07,2023
New type of immune cell discovered in breast ducts

New type of immune cell discovered in breast ducts

byWalter and Eliza Hall InstituteThe mammary gland is a dynamic organ that undergoes dramatic remodelling throughout life. The branching ducts bloom to form milk-producing 'factories' in
World medicine December 07,2023
New type of immune cell discovered in breast ducts

New type of immune cell discovered in breast ducts

byWalter and Eliza Hall InstituteThe mammary gland is a dynamic organ that undergoes dramatic remodelling throughout life. The branching ducts bloom to form milk-producing 'factories' in
World medicine December 07,2023
Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA team of researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATA
World medicine December 07,2023
Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA team of researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATA
World medicine December 07,2023
CBD shows promise for fighting aggressive brain cancer

CBD shows promise for fighting aggressive brain cancer

by Experimental BiologyThe researchers believe that CBD's anti-cancer actions target mitochondria -- the cell's energy producing structures -- by causing the mitochondria to dysfunction and re
World medicine December 07,2023
CBD shows promise for fighting aggressive brain cancer

CBD shows promise for fighting aggressive brain cancer

by Experimental BiologyThe researchers believe that CBD's anti-cancer actions target mitochondria -- the cell's energy producing structures -- by causing the mitochondria to dysfunction and re
World medicine December 07,2023
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

byFred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainPatients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vac
World medicine December 07,2023
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

byFred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainPatients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vac
World medicine December 07,2023
National kidney cancer study shows promising results

National kidney cancer study shows promising results

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainUC Davis Comprehensive Cancer Center has taken part in testing the anti-cancer drug everolimus as part of a phase III clinical trial t
World medicine December 07,2023
National kidney cancer study shows promising results

National kidney cancer study shows promising results

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainUC Davis Comprehensive Cancer Center has taken part in testing the anti-cancer drug everolimus as part of a phase III clinical trial t
World medicine December 07,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com